摘要
截至2000年,世界范围内约有150000000的成年糖尿病患者,这个数字将会在2030年增长到366000000。而在中国,糖尿病及糖尿病前期的患病率已分别达到9.7%及15.5%流行病学研究显示,
出处
《实用糖尿病杂志》
2011年第6期4-6,共3页
Journal of Practical Diabetology
参考文献7
-
1Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047 - 1053.
-
2Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2001 ;362:1090 -1101.
-
3Burcelin R, Knauf C, Cani PD. Pancreatic α - cell dysfunction in diabetes. Diabetes Metab 34 Suppl 2008 ;2 : S49 - S55.
-
4Dunning BE, Foley JEO Ahren B. A cell function in health and disease: influence of glucagon - like peptide- 1. Diabetologia 2005 ; 48: 1700-1713.
-
5Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10 - year follow - up of intensive glucose control in type 2 diabetes. N Engl J Med 2008 ;359:1577 - 1589.
-
6Effect of intensive blood - glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 ;352 : 854 - 865.
-
7Donnandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of rnacrovascular events in patients with type 2 diabetes in the PROactive Study ( PROspective pioglitAzone Clinical Trial In macroVascular Events ): a randomised controlled trial. Lancet 2005; 366, 1279 - 1289.
同被引文献6
-
1Smyth S Heron.Diabetes and obesity: the twin epidemics. Nat Med, 2005,12:75-80.
-
2Lehy JL.Pathogenesis of type 2 dia- betes mellitus. Arch Med Res, 2005,36: 197-209.
-
3Azumak, Rad ~ Kova Z, Mancino J, et al. Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor Vidagliptin in patients with type 2 diabetes.J Clin Endocrinol Metab, 2008(93) : 459-464.
-
4宁光.肠促胰素在血糖稳态调节和2型糖尿病治疗中的作用[J].中华内分泌代谢杂志,2010,26(9):836-839. 被引量:24
-
5童南伟.中国成人住院患者高血糖管理目标专家共识[J].中华内分泌代谢杂志,2013,29(3):189-195. 被引量:136
-
6刘赫.糖尿病与相关性高血压的临床识别及处理[J].实用糖尿病杂志,2013,9(2):4-6. 被引量:1
-
1孙建鑫.肺结核强化治疗中的类赫氏反应(附15例报告)[J].中国疗养医学,1996,5(1):77-78.
-
2宗先达.瑞舒伐他汀强化治疗冠心病并发阵发性心房颤动35例效果观察[J].慢性病学杂志,2014,14(4):307-309. 被引量:4
-
3汪道贵.胰岛素泵与皮下注射强化疗法治疗初发2型糖尿病的临床分析[J].世界最新医学信息文摘,2015,15(14):27-28. 被引量:2
-
4王凌灵.为2型糖尿病患者联用胰岛素泵强化疗法与吡格列酮进行治疗的效果分析[J].当代医药论丛,2016,14(5):171-172. 被引量:2
-
5糖尿病强化疗法不易诱发低血糖[J].中国社区医师,2007,23(18):18-18.
-
6王桂霞.初诊2型糖尿病应用胰岛素强化治疗的临床分析[J].实用糖尿病杂志,2011,7(4):47-48. 被引量:1
-
7良介.强化疗法依然是实现血糖达标的主要方法[J].实用糖尿病杂志,2010,6(3):62-62.
-
8张颖,魏简汇,翟保同,郑芝欣.阿托伐他汀强化疗法对高血压并发ST段抬高急性心肌梗死患者心脏功能与Lp-PLA2影响的研究[J].重庆医学,2016,45(36):5098-5100. 被引量:3
-
9欧造国,杨刚毅,刘纯,王秀华.胰岛素强化治疗非胰岛素依赖性糖尿病的血糖自我监测[J].重庆医科大学学报,1998,23(4):369-371.
-
10张星映,冉爱琴,马力群,程秦娣.诺和灵强化治疗糖尿病肾病临床疗效分析[J].西安医科大学学报,1999,20(2):223-225. 被引量:3